AARD Aardvark Therapeutics, Inc. - Common Stock
AARD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
AARD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
AARD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 5 27,8%
- Kauf 6 33,3%
- Halten 5 27,8%
- Verkauf 2 11,1%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-19Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.99 | $-0.89 | -0.10% |
| 31. Dezember 2025 | $-0.81 | $-0.85 | 0.04% |
| 30. September 2025 | $-0.75 | $-0.81 | 0.06% |
| 30. Juni 2025 | $-0.66 | $-0.61 | -0.05% |
| 31. März 2025 | $-0.71 | $-0.69 | -0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| NRXP | — | — | — | — | — | — |
| NTHI | — | -2.6 | -51.8% | — | — | — |
| CPIX | $60M | -20.9 | 17.6% | -6.4% | -11.9% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 |
|---|---|---|
| Revenue | $0 | |
| R&D Expense | $49M | |
| SG&A Expense | $14M | |
| Operating Expenses | $63M | |
| Operating Income | $-63M | |
| Interest Income | $5M | |
| Other Non-op | $5M | |
| Income Tax | $0 | |
| Net Income | $-58M | |
| EPS (Basic) | $-2.93 | |
| EPS (Diluted) | $-2.93 | |
| Shares (Basic) | 19,624,626 | |
| Shares (Diluted) | 19,624,626 | |
| EBITDA | $-63M |
Bilanz 18
| Kennzahl | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $47M | |
| Short-term Investments | $63M | |
| Prepaid Expense | $2M | |
| Current Assets | $112M | |
| Other Non-current Assets | $5M | |
| Total Assets | $117M | |
| Accounts Payable | $2M | |
| Accrued Liabilities | $8M | |
| Current Liabilities | $11M | |
| Capital Leases | $0 | |
| Other Non-current Liabilities | $0 | |
| Total Liabilities | $11M | |
| Common Stock | $0 | |
| Retained Earnings | $-116M | |
| AOCI | $81.0K | |
| Stockholders' Equity | $107M | |
| Liabilities + Equity | $117M | |
| Shares Outstanding | 21,815,353 |
Cashflow 10
| Kennzahl | Trend | 2025 |
|---|---|---|
| D&A | $36.0K | |
| Stock-based Comp | $4M | |
| Other Non-cash | $-565.0K | |
| Operating Cash Flow | $-54M | |
| CapEx | $95.0K | |
| Investing Cash Flow | $-50M | |
| Stock Issued | $195.0K | |
| Net Stock Activity | $195.0K | |
| Financing Cash Flow | $89M | |
| Free Cash Flow | $-54M |
Rentabilität 2
| Kennzahl | Trend | 2025 |
|---|---|---|
| ROA | -59.2% | |
| ROE | -47.3% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 |
|---|---|---|
| Current Ratio | 10.6 | |
| Quick Ratio | 10.4 |
Effizienz 1
| Kennzahl | Trend | 2025 |
|---|---|---|
| Asset Turnover | 0.0 |
Bewertung (TTM) 9
| Kennzahl | Trend | 2025 |
|---|---|---|
| Revenue TTM | $0 | |
| Net Income TTM | $-58M | |
| Market Cap | $286M | |
| P/E | -4.5 | |
| P/B | 2.7 | |
| P / Tangible Book | 2.7 | |
| P / Cash Flow | -5.3 | |
| P / FCF | -5.3 | |
| Earnings Yield | -22.3% |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $10M | $17M | $14M | $14M | $13M | $8M | |
| SG&A Expense | $5M | $6M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $15M | $22M | $19M | $18M | $16M | $10M | |
| Operating Income | $-15M | $-22M | $-19M | $-18M | $-16M | $-10M | |
| Interest Income | $695.0K | $889.0K | $1M | $1M | $1M | $1M | |
| Other Non-op | $697.0K | $876.0K | $1M | $1M | $1M | $1M | |
| Net Income | $-14M | $-22M | $-18M | $-16M | $-14M | $-9M | |
| EPS (Basic) | $-0.66 | $-0.99 | $-0.81 | $-0.75 | $-0.66 | $-0.71 | |
| EPS (Diluted) | $-0.66 | $-0.99 | $-0.81 | $-0.75 | $-0.66 | $-0.71 | |
| Shares (Basic) | 21,846,251 | 21,815,995 | -36,974,225 | 21,713,858 | 21,690,275 | 13,194,718 | |
| Shares (Diluted) | 21,846,251 | 21,815,995 | -36,974,225 | 21,713,858 | 21,690,275 | 13,194,718 | |
| EBITDA | $-15M | · | · | $-18M | $-16M | $-10M |
Bilanz 18
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $62M | $47M | $39M | $26M | $27M | |
| Short-term Investments | $21.0K | $29M | $63M | $87M | $116M | $125M | |
| Prepaid Expense | $7M | $2M | $2M | $3M | $3M | $3M | |
| Current Assets | $81M | $94M | $112M | $129M | $145M | $155M | |
| Other Non-current Assets | $173.0K | $5M | $5M | $4M | $2M | $2M | |
| Total Assets | $81M | $99M | $117M | $133M | $147M | $157M | |
| Accounts Payable | $2M | $4M | $2M | $4M | $5M | $3M | |
| Accrued Liabilities | $4M | $7M | $8M | $6M | $5M | $3M | |
| Current Liabilities | $6M | $12M | $11M | $11M | $10M | $6M | |
| Capital Leases | $276.0K | · | $0 | $116.0K | $228.0K | $336.0K | |
| Other Non-current Liabilities | · | · | $0 | $0 | $12.0K | $24.0K | |
| Total Liabilities | $7M | $12M | $11M | $11M | $11M | $6M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-152M | $-138M | $-116M | $-98M | $-82M | $-68M | |
| AOCI | $0 | $14.0K | $81.0K | $82.0K | $-3.0K | $44.0K | |
| Stockholders' Equity | $75M | $87M | $107M | $122M | $137M | $151M | |
| Liabilities + Equity | $81M | $99M | $117M | $133M | $147M | $157M | |
| Shares Outstanding | 21,884,158 | 21,816,385 | 21,815,353 | 21,745,265 | 21,693,016 | 21,688,172 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| D&A | $11.0K | $11.0K | $10.0K | $10.0K | $11.0K | $5.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $634.0K | $233.0K | |
| Other Non-cash | · | · | · | · | · | $-2M | |
| Operating Cash Flow | $-18M | $-19M | $-17M | $-16M | $-10M | $-11M | |
| CapEx | · | · | $0 | $4.0K | $91.0K | $0 | |
| Investing Cash Flow | $29M | $34M | $24M | $29M | $9M | $-113M | |
| Financing Cash Flow | $262.0K | $4.0K | $274.0K | $171.0K | $-71.0K | $89M | |
| Free Cash Flow | · | · | · | · | · | $-11M |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| ROA | -12.6% | · | · | -24.5% | -19.5% | -11.9% | |
| ROE | -13.6% | · | · | -26.7% | -21.0% | -12.4% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 12.6 | · | · | 12.0 | 14.0 | 25.9 | |
| Quick Ratio | 11.6 | · | · | 11.8 | 13.8 | 25.3 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-67M | $-62M | · | $-44M | $-33M | $-21M | |
| Market Cap | $126M | · | · | $289M | $293M | $163M | |
| P/E | -1.9 | -1.2 | · | -4.2 | -3.6 | -2.0 | |
| P/B | 1.7 | · | · | 2.4 | 2.1 | 1.1 | |
| P / Tangible Book | 1.7 | 0.9 | · | 2.4 | 2.1 | 1.1 | |
| P / Cash Flow | · | · | · | · | · | -14.3 | |
| P / FCF | · | · | · | · | · | -14.3 | |
| Earnings Yield | -53.1% | -82.5% | · | -23.8% | -28.0% | -49.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Umsatz | $0 | — |
| Nettoergebnis | $-58M | $-21M |
| Verwässerte EPS | $-2.93 | $-5.15 |
Bilanz
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Liquiditätsgrad | 10.6 | — |
| Quick Ratio | 10.4 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Freier Cashflow | $-54M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 80 Einreicher · $51.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 23 (-7 vs. Vorquartal) | 22 (+6 vs. Vorquartal) | 20 (+4 vs. Vorquartal) | 22 (+2 vs. Vorquartal) | +203K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Decheng Capital LLC | $22.563.642 | 3.917.299 | 44,07% | Aktien |
| CITADEL ADVISORS LLC | $7.155.516 | 1.242.277 | 13,98% | Aktien |
| Laurion Capital Management LP | $5.958.484 | 1.034.459 | 11,64% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.242.172 | 562.877 | 6,33% | Aktien |
| EcoR1 Capital, LLC | $2.282.077 | 396.194 | 4,46% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $1.728.000 | 300.000 | 3,37% | Aktien |
| VANGUARD GROUP INC | $1.092.643 | 83.249 | 2,13% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $703.010 | 121.976 | 1,37% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $624.252 | 108.377 | 1,22% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $432.991 | 75.172 | 0,85% | Aktien |
| Woodline Partners LP | $417.191 | 72.429 | 0,81% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $402.900 | 69.948 | 0,79% | Aktien |
| CANTOR FITZGERALD, L. P. | $384.088 | 66.682 | 0,75% | Aktien |
| TWO SIGMA ADVISERS, LP | $343.875 | 26.200 | 0,67% | Aktien |
| STATE STREET CORP | $341.412 | 59.273 | 0,67% | Aktien |
| CITADEL ADVISORS LLC | $340.416 | 59.100 | 0,66% | Verkaufsoption |
| J. Goldman & Co LP | $233.280 | 40.500 | 0,46% | Aktien |
| IEQ CAPITAL, LLC | $221.080 | 38.382 | 0,43% | Aktien |
| UBS Group AG | $179.205 | 31.112 | 0,35% | Aktien |
| NORTHERN TRUST CORP | $161.482 | 28.035 | 0,32% | Aktien |
| CITIGROUP INC | $151.482 | 26.299 | 0,30% | Aktien |
| Cresset Asset Management, LLC | $138.430 | 24.033 | 0,27% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $138.384 | 24.025 | 0,27% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $138.240 | 24.000 | 0,27% | Aktien |
| JANE STREET GROUP, LLC | $133.632 | 23.200 | 0,26% | Verkaufsoption |
| Point72 Asset Management, L.P. | $131.743 | 22.872 | 0,26% | Aktien |
| MORGAN STANLEY | $130.833 | 22.714 | 0,26% | Aktien |
| Mariner, LLC | $125.408 | 21.784 | 0,24% | Aktien |
| SMITH, MOORE & CO. | $115.200 | 20.000 | 0,22% | Aktien |
| XTX Topco Ltd | $114.555 | 19.888 | 0,22% | Aktien |
| FMR LLC | $108.887 | 18.904 | 0,21% | Aktien |
| SIMPLEX TRADING, LLC | $91.681 | 15.917 | 0,18% | Aktien |
| EcoR1 Capital, LLC | $84.672 | 14.700 | 0,17% | Kaufoption |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $79.298 | 10.434 | 0,15% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $71.574 | 12.426 | 0,14% | Aktien |
| GOLDMAN SACHS GROUP INC | $70.508 | 12.241 | 0,14% | Aktien |
| JANE STREET GROUP, LLC | $67.484 | 11.716 | 0,13% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $66.033 | 11.464 | 0,13% | Aktien |
| Abel Hall, LLC | $57.980 | 10.066 | 0,11% | Aktien |
| Arax Advisory Partners | $48.234 | 8.374 | 0,09% | Aktien |
| Cerity Partners LLC | $43.246 | 7.508 | 0,08% | Aktien |
| MARSHALL WACE, LLP | $38.524 | 6.688 | 0,08% | Aktien |
| Vanguard Global Advisers, LLC | $33.944 | 5.893 | 0,07% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $27.498 | 4.774 | 0,05% | Aktien |
| Steward Partners Investment Advisory, LLC | $23.904 | 4.150 | 0,05% | Aktien |
| CWM, LLC | $22.752 | 6.035 | 0,04% | Aktien |
| China Universal Asset Management Co., Ltd. | $19.999 | 3.472 | 0,04% | Aktien |
| BlackRock, Inc. | $15.696 | 2.725 | 0,03% | Aktien |
| Tower Research Capital LLC (TRC) | $14.406 | 2.501 | 0,03% | Aktien |
| Integrated Wealth Concepts LLC | $11.194 | 1.943 | 0,02% | Aktien |
| BARCLAYS PLC | $9.072 | 1.575 | 0,02% | Aktien |
| JPMORGAN CHASE & CO | $8.961 | 1.730 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $7.534 | 1.308 | 0,01% | Aktien |
| Russell Investments Group, Ltd. | $7.137 | 1.239 | 0,01% | Aktien |
| Stone House Investment Management, LLC | $5.760 | 1.000 | 0,01% | Aktien |
| Mirae Asset Global Investments Co., Ltd. | $5.622 | 976 | 0,01% | Aktien |
| Allworth Financial LP | $4.683 | 813 | 0,01% | Aktien |
| FEDERATED HERMES, INC. | $3.721 | 646 | 0,01% | Aktien |
| Essential Partners LLC | $2.932 | 509 | 0,01% | Aktien |
| GF FUND MANAGEMENT CO. LTD. | $2.604 | 452 | 0,01% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.598 | 689 | 0,01% | Aktien |
| IFP Advisors, Inc | $2.575 | 447 | 0,01% | Aktien |
| Hilton Head Capital Partners, LLC | $2.500 | 434 | 0,00% | Aktien |
| GAMMA Investing LLC | $2.235 | 388 | 0,00% | Aktien |
| PNC Financial Services Group, Inc. | $2.010 | 349 | 0,00% | Aktien |
| ROTHSCHILD INVESTMENT LLC | $1.526 | 265 | 0,00% | Aktien |
| EverSource Wealth Advisors, LLC | $1.025 | 178 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $1.000 | 150 | 0,00% | Aktien |
| True Wealth Design, LLC | $934 | 162 | 0,00% | Aktien |
| Farther Finance Advisors, LLC | $867 | 153 | 0,00% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $403 | 70 | 0,00% | Aktien |
| Fortitude Family Office, LLC | $323 | 56 | 0,00% | Aktien |
| HARBOUR INVESTMENTS, INC. | $304 | 53 | 0,00% | Aktien |
| Wealth Enhancement Trust Services, Inc. | $276 | 48 | 0,00% | Aktien |
| Clearstead Advisors, LLC | $226 | 39 | 0,00% | Aktien |
| SJS Investment Consulting Inc. | $93 | 16 | 0,00% | Aktien |
| Transamerica Financial Advisors, LLC | $80 | 14 | 0,00% | Aktien |
| JPL Wealth Management, LLC | $41 | 7 | 0,00% | Aktien |
| Sunbelt Securities, Inc. | $15 | 4 | 0,00% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $6 | 1 | 0,00% | Aktien |
Unternehmensinsider 9 Insider · 4 Führungskräfte · 5 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Tien-Li Lee | Chief Executive Officer | 9. Februar 2026 A | 1.551.613 | 6 | 0 | $358.575 |
| Nelson Sun | Chief Financial Officer | 9. Februar 2026 A | 108.484 | 2 | 0 | $91.620 |
| Bryan Jones | Chief Operating Officer | 15. Oktober 2025 M | 1.250 | 0 | 0 | $0 |
| Manasi Jaiman | Chief Medical Officer | 9. Februar 2026 A | — | 0 | 0 | $0 |
| Victor Edward Tong Jr | Direktor | 11. Juni 2025 A | — | 0 | 0 | $0 |
| Jeffrey Chi | Direktor | 11. Juni 2025 A | 133.364 | 0 | 0 | $0 |
| Roy D. Baynes | Direktor | 11. Juni 2025 A | — | 0 | 0 | $0 |
| Susan E Graf | Direktor | 11. Juni 2025 A | — | 0 | 0 | $0 |
| Vickers Venture Fund VI Pte Ltd | 10%-Eigentümer | 14. Februar 2025 C | 2.050.902 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 11 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,06% | 22.439 NS | 31. Mai 2026 | N-PORT |
| IWC · iShares Trust | 0,02% | 42.615 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 1.175 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,01% | 92.100 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,00% | 804 NS | 31. Mai 2026 | N-PORT |
| ITWO · ProShares Trust | 0,00% | 600 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 469 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 475 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 12 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 140.389 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 408.670 SH | 8. August 2026 | Täglich |